December 16th 2025.
On Tuesday, the government of Odisha revealed its new Pharmaceutical and Medical Devices Policy for the year 2025. The aim of this policy is to attract investments worth Rs 25,000 crore and create 1 lakh job opportunities by the year 2030. The policy was launched by Chief Minister Mohan Charan Majhi during the Odisha Pharma Summit-2025, in the presence of Industries Minister Sampad Chandra Swain and other senior government officials.
During the launch, Additional Chief Secretary of the Industries Department, Hemant Sharma, highlighted the huge potential for growth in the pharmaceutical and medical devices sector as India currently imports about 85% of its medical devices from other countries. He emphasized the need for Odisha to become a part of this growing sector and encouraged the state to take advantage of the upcoming opportunities.
Under the new policy, the state is offering a 50% subsidy on concessional land cost for units that employ more than 200 skilled staff from Odisha. Additionally, a 30% capital subsidy will be provided for eligible plant and machinery without any upper limit, and a 25% subsidy will be given for dedicated power infrastructure.
The main objective of this policy is to establish Odisha as the eastern hub for pharmaceuticals and medical devices by attracting investments, creating jobs, promoting innovation, and encouraging green manufacturing. It is estimated that this policy will bring in an investment of Rs 25,000 crore and generate employment for 1 lakh individuals by 2030. In fact, on the very day of its launch, MoUs worth Rs 5,000 crore were already signed.
Apart from promoting investments and job creation, this policy also aims to boost local entrepreneurship and MSME growth, while creating employment opportunities for skilled and semi-skilled workers. It is built upon the state's Industrial Policy Resolution 2022, which identifies pharmaceuticals, bulk drugs, and medical devices as thrust sectors. The policy also focuses on infrastructure development, research excellence, industry-academia collaboration for skill development, and a facilitative regulatory environment to promote inclusive and sustainable industrial growth.
As part of this policy, the state will establish an Odisha Pharma Park and an Odisha MedTech Park as integrated, good manufacturing practices-ready clusters. It will also provide a combination of land, finance, skilled workforce, regulatory support, and R&D assistance to attract anchor investments across various areas such as active pharmaceutical ingredients, formulations, vaccines, diagnostics, imaging, implants, and wearables. This will position Odisha as a competitive and sustainable destination for manufacturing and innovation.
The policy covers a wide range of pharmaceutical products including APIs, bulk drugs, formulations, vaccines, biologicals, and nutraceuticals, as well as medical devices such as in-vitro diagnostics, implants, surgical consumables, and medical wearables. It also includes digital health devices and device software.
Overall, the new Pharmaceutical and Medical Devices Policy-2025 is a significant step towards making Odisha a leader in the pharmaceutical and medical devices sector, and it is expected to bring immense benefits to the state's economy. This policy is a testament to Odisha's commitment towards promoting inclusive and sustainable industrial development.
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]
